CNO insider plans sale of 45,357 shares
CNO Financial insider Gary Bhojwani filed a notice to sell 45,357 shares of CNO common stock under Rule 144.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
CNO Financial insider Gary Bhojwani filed a notice to sell 45,357 shares of CNO common stock under Rule 144. The planned sale, through Morgan Stanley Smith Barney on the NYSE around 02/17/2026, has an aggregate market value of 1957866.65.
The shares to be sold are performance shares of common stock acquired from the issuer on 02/10/2026. In the past three months, Bhojwanii also sold 31,430 common shares on 01/02/2026 for gross proceeds of 1319641.98 and 31,430 shares on 11/20/2025 for 1256222.53.
Insights
Routine Rule 144 filing for a planned insider stock sale.
The notice shows Gary Bhojwani intends to sell 45,357 CNO common shares via Morgan Stanley Smith Barney on the NYSE, with an indicated aggregate market value of 1957866.65. The shares were recently acquired as performance shares from the issuer.
The filing also lists two prior sales of 31,430 common shares each, on 11/20/2025 and 01/02/2026, for gross proceeds of 1256222.53 and 1319641.98. This appears to be a planned liquidity event rather than a disclosed change in the company’s operations or financial outlook.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What does the latest Form 144 filing for CNO (CNO) disclose?
What prior CNO (CNO) stock sales by Gary Bhojwani are disclosed?
AI-generated analysis. How Rhea-AI works. Not financial advice.